News
Thursday, March 28th, 2013
Diabetes Care: April 1, 2013 Reversal of type 2 diabetes to normal metabolic control by either bariatric surgery or hypocaloric diet allows for the time sequence of underlying pathophysiologic mechanisms to be observed. In reverse order, the same mechanisms are likely to determine the events leading to the onset of hyperglycemia and permit insight into […]
News
Thursday, March 28th, 2013
Diabetes Care: April 1, 2013 Methods for monitoring blood glucose (BG) levels play many essential roles in diabetes management, and one of the most important is alerting individuals to the occurrence of hypoglycemia. A growing number of individuals with diabetes are turning to the use of Diabetic Alert Dogs (DADs) for hypoglycemia detection, despite their […]
News
Thursday, March 28th, 2013
Johnson & Johnson: March 25, 2013 LifeScan, Inc. is initiating a voluntary recall and replacement for all of its OneTouch® Verio®IQ blood glucose meters in the United States, effective immediately. LifeScan is recalling and replacing all OneTouch® Verio®IQ Meters because at extremely high blood glucose levels of 1024 mg/dL and above, the meter will not provide […]
News
Thursday, March 28th, 2013
CDC: March 22, 2013 In 2010, approximately one in three U.S. adults aged ≥20 years (an estimated 79 million persons) had prediabetes, a condition in which blood glucose or hemoglobin A1c (A1c) levels are higher than normal but not high enough to be classified as diabetes (1). Persons with prediabetes are at high risk for […]
News
Thursday, March 28th, 2013
Diabetes Care: November 8, 2012 OBJECTIVE To describe the association of BMI with mortality in patients diagnosed with type 2 diabetes. RESEARCH DESIGN AND METHODS Using records of 106,640 patients in Scotland, we investigated the association between BMI recorded around the diagnosis of type 2 diabetes mellitus (T2DM) and mortality using Cox proportional hazards regression adjusted for age […]
Minority Diabetes Reports
Wednesday, March 20th, 2013
The Diabetes Educator: March 12, 2013 Purpose The objective of this study is to examine the differences in receipt of diabetes education according to risk factors that are associated with the disease, including race/ ethnicity, region, and rural/urban location. Methods National data from the 2007 Medical Expenditure Panel Survey (MEPS) were analyzed to examine likelihood of receipt of […]
Minority Diabetes Reports
Wednesday, March 20th, 2013
Ann Fam Medicine: March 1, 2013 PURPOSE Rural low-income African American patients with diabetes have traditionally poorer clinical outcomes and limited access to state-of-the-art diabetes care. We determined the effectiveness of a redesigned primary care model on patients’ glycemic, blood pressure, and lipid level control. METHODS In 3 purposively selected, rural, fee-for-service, primary care practices, African American […]
Minority Diabetes Reports
Wednesday, March 20th, 2013
JCR: February 1, 2013 Background: Although a higher prevalence of osteoarthritis (OA) has been reported among diabetes mellitus (DM) patients, inconsistencies and limitations of observational studies have precluded a conclusive association. Objective: The objective of this study was to evaluate the association of hand or knee OA with DM in a population of Hispanics from […]
Clinical Trials
Wednesday, March 20th, 2013
AJPM: April 1, 2013 Background Since the Diabetes Prevention Project (DPP) demonstrated that lifestyle weight-loss interventions can reduce the incidence of diabetes by 58%, several studies have translated the DPP methods to public health−friendly contexts. Although these studies have demonstrated short-term effects, no study to date has examined the impact of a translated DPP intervention […]
Clinical Trials
Wednesday, March 20th, 2013
Informa Health Care: March 18, 2013 The present study was aimed to evaluate the effects of Zingiber officinale on some biochemical parameters in type 2 diabetic (DM2) patients. In a randomized double-blind placebo controlled trial, 64 patients with DM2 were assigned to ginger or placebo groups (receiving 2 g/d of each). Read more